BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17876520)

  • 1. Cytoplasmic fatty acid binding protein sensing fatty acids for peroxisome proliferator activated receptor activation.
    Wolfrum C
    Cell Mol Life Sci; 2007 Oct; 64(19-20):2465-76. PubMed ID: 17876520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors.
    Ferreira AM; Minarrieta L; Lamas Bervejillo M; Rubbo H
    Free Radic Biol Med; 2012 Nov; 53(9):1654-63. PubMed ID: 22982052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives.
    Grimaldi PA
    Cell Mol Life Sci; 2007 Oct; 64(19-20):2459-64. PubMed ID: 17876521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription.
    Schroeder F; Petrescu AD; Huang H; Atshaves BP; McIntosh AL; Martin GG; Hostetler HA; Vespa A; Landrock D; Landrock KK; Payne HR; Kier AB
    Lipids; 2008 Jan; 43(1):1-17. PubMed ID: 17882463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PPARs-mediated intracellular signal transduction].
    Fujii H
    Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor β/δ (FABP5-PPARβ/δ) signaling pathway.
    Armstrong EH; Goswami D; Griffin PR; Noy N; Ortlund EA
    J Biol Chem; 2014 May; 289(21):14941-54. PubMed ID: 24692551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner.
    Hughes ML; Liu B; Halls ML; Wagstaff KM; Patil R; Velkov T; Jans DA; Bunnett NW; Scanlon MJ; Porter CJ
    J Biol Chem; 2015 May; 290(22):13895-906. PubMed ID: 25847235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop.
    Colasante C; Chen J; Ahlemeyer B; Baumgart-Vogt E
    Thromb Haemost; 2015 Mar; 113(3):452-63. PubMed ID: 25608554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?
    Ziouzenkova O; Plutzky J
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):369-75. PubMed ID: 15192437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors and the control of fatty acid oxidation in cardiac hypertrophy.
    Planavila A; Calvo RR; Vázquez-Carrera M
    Mini Rev Med Chem; 2006 Mar; 6(3):357-63. PubMed ID: 16515475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular lipid binding proteins and nuclear receptors involved in branched-chain fatty acid signaling.
    Adida A; Spener F
    Prostaglandins Leukot Essent Fatty Acids; 2002; 67(2-3):91-8. PubMed ID: 12324226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARs: fatty acid sensors controlling metabolism.
    Poulsen Ll; Siersbæk M; Mandrup S
    Semin Cell Dev Biol; 2012 Aug; 23(6):631-9. PubMed ID: 22273692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acids and immune responses--a new perspective in searching for clues to mechanism.
    Hwang D
    Annu Rev Nutr; 2000; 20():431-56. PubMed ID: 10940341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.
    Wolfrum C; Borrmann CM; Borchers T; Spener F
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2323-8. PubMed ID: 11226238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SnapShot: FABP Functions.
    Li B; Hao J; Zeng J; Sauter ER
    Cell; 2020 Aug; 182(4):1066-1066.e1. PubMed ID: 32822569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC; Popeijus HE
    Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.
    Schachtrup C; Emmler T; Bleck B; Sandqvist A; Spener F
    Biochem J; 2004 Aug; 382(Pt 1):239-45. PubMed ID: 15130092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder.
    Barone R; Rizzo R; Tabbì G; Malaguarnera M; Frye RE; Bastin J
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.